Cited by 79Dermatology and Skin DiseasesAdrenal Hormones and DisordersCholesterol and Lipid Metabolism

Cutaneous glucocorticosteroidogenesis: securing local homeostasis and the skin integrity

Open access
Slominski, Andrzej T., Manna, Pulak R., Tuckey, Robert C.·2014·Experimental Dermatology

Abstract

Human skin has the ability to synthesize glucocorticoids de novo from cholesterol or from steroid intermediates of systemic origin. By interacting with glucocorticoid receptors, they regulate skin immune functions as well as functions and phenotype of the epidermal, dermal and adnexal compartments. Most of the biochemical (enzyme and transporter activities) and regulatory (neuropeptides mediated activation of cAMP and protein kinase A dependent pathways) principles of steroidogenesis in the skin are similar to those operating in classical steroidogenic organs. However, there are also significant differences determined by the close proximity of synthesis and action (even within the same cells) allowing para-, auto- or intracrine modes of regulation. We also propose that ultraviolet light B (UVB) can regulate the availability of 7-dehydrocholesterol for transformation to cholesterol with its further metabolism to steroids, oxysterols or ∆7 steroids, because of its transformation to vitamin D3. In addition, UVB can rearrange locally produced ∆7 steroids to the corresponding secosteroids with a short- or no-side chain. Thus, different mechanisms of regulation occur in the skin that can be either stochastic or structuralized. We propose that local glucocorticosteroidogenic systems and their regulators, in concert with cognate receptors operate to stabilize skin homeostasis and prevent or attenuate skin pathology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/exd.12376

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Organs expressing lower levels of CYP11A1 such as skin and gastrointestinal tract can metabolize vitamin D3 through the novel CYP11A1-initiated pathway, as an additional and alternative pathway to the classical one.

    “These data indicate that organs expressing lower levels of CYP11A1 such as skin [15,66] and gastrointestinal (GI) tract [111] can metabolize D3 through the novel CYP11A1-initiated pathway, as an additional and alternative pathway to the classical one.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 123

  1. [1]Grando SA Pittelkow MR Schallreuter KU J Invest Dermatol 2006 126 1948 1965 16912692
  2. [2]Botchkarev VA Yaar M Peters EM J Invest Dermatol 2006 126 1719 1727 16845411
  3. [3]Feingold KR Schmuth M Elias PM J Invest Dermatol 2007 127 1574 1576 17568800
  4. [4]Elias PM Menon G Wetzel BK Am J Hum Biol 2010 22 526 537 20209486 PMC3071612
  5. [5]Slominski A Zbytek B Nikolakis G J Steroid Biochem Mol Biol 2013 137 107 123 23435015 PMC3674137
  6. [7]Slominski AT Zmijewski MA Semak I Anti-Cancer Agents Med Chem 2014 14 77 96 PMC3740756 23869782
  7. [8]Slominski A Wortsman J Endocr Rev 2000 21 457 487 11041445
  8. [9]Botchkarev VA Gdula MR Mardaryev AN J Invest Dermatol 2012 132 2505 2521 22763788 PMC3650472
  9. [10]Eckert RL Crish JF Robinson NA Physiol Rev 1997 77 397 424 9114819
  10. [11]Slominski AT Zmijewski MA Skobowiat C Adv Anat Embryol Cell Biol 2012 212 v vii 1 115 22894052 PMC3422784
  11. [12]Elias PM Williams ML Feingold KR Clin Dermatol 2012 30 311 322 22507046 PMC3607361
  12. [13]Stenn KS Paus R Physiol Rev 2001 81 449 494 11152763
  13. [14]Chen WC Zouboulis CC Dermatoendocrinol 2009 1 81 86 20224689 PMC2835896
  14. [15]Gilhar A Etzioni A Paus R N Engl J Med 2012 366 1515 1525 22512484
  15. [16]Slominski A Tobin DJ Shibahara S Physiol Rev 2004 84 1155 1228 15383650
  16. [17]Slominski A Wortsman J Plonka PM J Invest Dermatol 2005 124 13 21 15654948 PMC1201498
  17. [18]Di Meglio P Perera GK Nestle FO Immunity 2011 35 857 869 22195743
  18. [19]Gallo RL Hooper LV Nat Rev Immunol 2012 12 503 516 22728527 PMC3563335
  19. [20]Roosterman D Goerge T Schneider SW Physiol Rev 2006 86 1309 1379 17015491
  20. [21]Klein J Permana PA Owecki M Exp Dermatol 2007 16 45 70 17181636
  21. [22]Slominski AT Zmijewski MA Zbytek B Endocr Rev 2013 34 827 884 23939821 PMC3857130
  22. [23]Miller WL Auchus RJ Endocr Rev 2011 32 81 151 21051590 PMC3365799
  23. [24]Miller WL Bose HS J Lipid Res 2011 52 2111 2135 21976778 PMC3283258
  24. [25]Tuckey RC Placenta 2005 26 273 281 15823613
  25. [26]Hu J Zhang Z Shen WJ Nutr Metab (Lond) 2010 7 47 20515451 PMC2890697
  26. [27]Tuckey RC Cameron KJ Biochim Biophys Acta 1993 1163 185 194 8490050
  27. [28]Anuka E Gal M Stocco DM Mol Cell Endocrinol 2013 371 47 61 23415713
  28. [29]Rainey WE Carr BR Sasano H Trends Endocrinol Metab 2002 13 234 239 12128283
  29. [30]Dorr HG Heller A Versmold HT J Clin Endocrinol Metab 1989 68 863 868 2715289
  30. [31]Talaber G Jondal M Okret S Mol Cell Endocrinol 2013 380 89 98 23707789
  31. [32]Taves MD Gomez-Sanchez CE Soma KK Am J Physiol Endocrinol Metab 2011 301 E11 E24 21540450 PMC3275156
  32. [33]Slominski A Ermak G Mihm M J Clin Endocrinol Metab 1996 81 2746 2749 8675607
  33. [34]Slominski A Gomez-Sanchez CE Foecking MF FEBS Lett 1999 455 364 366 10437805
  34. [35]Slominski A Zjawiony J Wortsman J Eur J Biochem 2004 271 4178 4188 15511223 PMC1201497
  35. [36]Slominski A Zbytek B Szczesniewski A Am J Physiol Endocrinol Metab 2005 288 E701 E706 15572653
  36. [37]Slominski A Zbytek B Semak I J Neuroimmunol 2005 162 97 102 15833364
  37. [38]Ito N Ito T Kromminga A FASEB J 2005 19 1332 1334 15946990
  38. [39]Slominski A Zbytek B Szczesniewski A J Invest Dermatol 2006 126 1177 1178 16484985 PMC1472636
  39. [40]Cirillo N Prime SS J Cell Biochem 2011 112 1499 1505 21344493
  40. [41]Hannen RF Michael AE Jaulim A Biochem Biophys Res Commun 2011 404 62 67 21094146
  41. [42]Vukelic S Stojadinovic O Pastar I J Biol Chem 2011 286 10265 10275 21239489 PMC3060481
  42. [43]Labrie F Luu-The V Labrie C Horm Res 2000 54 218 229 11595810
  43. [44]Reed MJ Purohit A Woo LW Endocr Rev 2005 26 171 202 15561802
  44. [45]Elias PM Williams ML Choi EH Biochim Biophys Acta 2014 1841 353 361 24291327 PMC3966299
  45. [46]Skobowiat C Sayre RM Dowdy JC Br J Dermatol 2013 168 595 601 23363016 PMC3586986
  46. [47]Slominski A Gomez-Sanchez C Foecking MF Biochim Biophys Acta 2000 1474 1 4 10699483
  47. [48]Skobowiat C Nejati R Lu L Gene 2013 530 1 7 23962689 PMC3807248
  48. [49]Slominski A Wortsman J Foecking MF J Invest Dermatol 2002 118 310 315 11841549
  49. [50]Holick MF Vitamin D J Cell Biochem 2003 88 296 307 12520530
  50. [51]Bikle DD Exp Dermatol 2011 20 7 13 21197695
  51. [52]Guryev O Carvalho RA Usanov S Proc Natl Acad Sci USA 2003 100 14754 14759 14657394 PMC299797
  52. [53]Slominski AT Kim TK Chen J Int J Biochem Cell Biol 2012 44 2003 2018 22877869 PMC3520099
  53. [54]Slominski AT Zmijewski MA Semak I PLoS ONE 2009 4 e4309 19190754 PMC2629546
  54. [55]Shackleton CH Lipids 2012 47 1 12 21874273 PMC3564490
  55. [56]Zmijewski MA Li W Zjawiony JK Steroids 2009 74 218 228 19028513 PMC2631623
  56. [57]Zmijewski MA Li W Chen J Steroids 2011 76 193 203 21070794 PMC3005096
  57. [58]Slominski AT Li W Bhattacharya SK J Invest Dermatol 2011 131 1167 1169 21228816 PMC3078214
  58. [59]Lathe R Steroids 2002 67 967 977 12398993
  59. [60]Larsson H Bottiger Y Iuliano L Free Radic Biol Med 2007 43 695 701 17664133
  60. [61]Hennebert O Montes M Favre-Reguillon A J Steroid Biochem Mol Biol 2009 114 57 63 19167490
  61. [62]Muller C Pompon D Urban P J Steroid Biochem Mol Biol 2006 99 215 222 16603347
  62. [63]Schweizer RA Zurcher M Balazs Z J Biol Chem 2004 279 18415 18424 14973125
  63. [64]Nashev LG Chandsawangbhuwana C Balazs Z PLoS ONE 2007 2 e561 17593962 PMC1891437
  64. [65]Jellinck PH Croft G McEwen BS J Steroid Biochem Mol Biol 2005 93 81 86 15748836
  65. [66]Chalbot S Morfin R Steroids 2005 70 319 326 15784286
  66. [67]Li A Bigelow JC Steroids 2010 75 404 410 20153344
  67. [68]Shinkyo R Xu L Tallman KA J Biol Chem 2011 286 33021 33028 21813643 PMC3190903
  68. [69]Endo-Umeda K Yasuda K Sugita K J Steroid Biochem Mol Biol 2014 140 7 16 24269243
  69. [70]Lin YY Welch M Lieberman S J Steroid Biochem Mol Biol 2003 85 57 61 12798357
  70. [71]Zouboulis CC Chen WC Thornton MJ Horm Metab Res 2007 39 85 95 17326004
  71. [72]Chen W Thiboutot D Zouboulis CC J Invest Dermatol 2002 119 992 1007 12445184
  72. [74]Slominski A Wortsman J Luger T Physiol Rev 2000 80 979 1020 10893429
  73. [75]Slominski A Zbytek B Pisarchik A J Cell Physiol 2006 206 780 791 16245303 PMC1351367
  74. [76]Slominski A J Clin Invest 2007 117 3166 3169 17975659 PMC2045620
  75. [77]Tiganescu A Tahrani AA Morgan SA J Clin Invest 2013 123 3051 3060 23722901 PMC3696573
  76. [78]Slominski A Wortsman J Tuckey RC Mol Cell Endocrinol 2007 265–266 143 149 PMC1839836 17197073
  77. [79]Zhu G Janjetovic Z Slominski A Exp Dermatol 2014 23 15 17 24372648 PMC3923494
  78. [80]Ermak G Slominski A J Invest Dermatol 1997 108 160 167 9008228
  79. [81]Slominski A Ermak G Mazurkiewicz JE J Clin Endocrinol Metab 1998 83 1020 1024 9506767
  80. [82]Skobowiat C Dowdy JC Sayre RM Am J Physiol Endocrinol Metab 2011 301 E484 E493 21673307 PMC3174533
  81. [83]Zbytek B Wortsman J Slominski A Mol Endocrinol 2006 20 2539 2547 16740657 PMC1847418
  82. [84]Edwards PA Kennedy MA Mak PA Vascul Pharmacol 2002 38 249 256 12449021
  83. [85]Lukyanenko YO Chen JJ Hutson JC Biol Re-prod 2001 64 790 796 11207193
  84. [86]King SR Matassa AA White EK J Mol Endocrinol 2004 32 507 517 15072555
  85. [87]Cummins CL Volle DH Zhang Y J Clin Invest 2006 116 1902 1912 16823488 PMC1483175
  86. [88]Manna PR Cohen-Tannoudji J Counis R J Biol Chem 2013 288 8505 8518 23362264 PMC3605665
  87. [89]Hanley K Ng DC He SS J Invest Dermatol 2000 114 545 553 10692116
  88. [90]Kielar D Kaminski WE Liebisch G J Invest Dermatol 2003 121 465 474 12925201
  89. [91]Schmuth M Jiang YJ Dubrac S J Lipid Res 2008 49 499 509 18182682
  90. [92]Repa JJ Berge KE Pomajzl C J Biol Chem 2002 277 18793 18800 11901146
  91. [93]Volle DH Lobaccaro JM Mol Cell Endocrinol 2007 265–266 183 189 17208362
  92. [94]Bushue N Wan YJ Adv Drug Deliv Rev 2010 62 1285 1298 20654663 PMC2991380
  93. [95]Torma H Dermatoendocrinol 2011 3 136 140 22110773 PMC3219164
  94. [96]Chapman MS Semin Cutan Med Surg 2012 31 11 16 22361284
  95. [97]Memezawa A Takada I Takeyama K Oncogene 2007 26 5038 5045 17310985
  96. [98]Esteban-Pretel G Marin MP Cabezuelo F J Nutr 2010 140 792 798 20181784
  97. [99]Chang KC Shen Q Oh IG Mol Endocrinol 2008 22 2407 2419 18787039
  98. [100]Hong I Rho HS Kim DH Arch Pharm Res 2010 33 1443 1449 20945144
  99. [101]Shen Q Bai Y Chang KC J Biol Chem 2011 286 14554 14563 21349840 PMC3077653
  100. [102]Komuves LG Schmuth M Fowler AJ J Invest Dermatol 2002 118 25 34 11851872
  101. [103]Fowler AJ Sheu MY Schmuth M J Invest Dermatol 2003 120 246 255 12542530
  102. [104]Yokoyama A Makishima M Choi M J Invest Dermatol 2009 129 1395 1401 19242521
  103. [105]Revollo JR Cidlowski JA Ann N Y Acad Sci 2009 1179 167 178 19906239
  104. [106]Sarabdjitsingh RA Joels M de Kloet ER Physiol Behav 2012 106 73 80 21971364
  105. [107]Lu NZ Cidlowski JA Mol Cell 2005 18 331 342 15866175
  106. [108]Duma D Jewell CM Cidlowski JA J Steroid Biochem Mol Biol 2006 102 11 21 17070034
  107. [109]Schacke H Rehwinkel H Asadullah K Exp Dermatol 2006 15 565 573 16842594
  108. [111]Perez P Page A Bravo A FASEB J 2001 15 2030 2032 11511512
  109. [112]Fuchs E Nature 2007 445 834 842 17314969 PMC2405926
  110. [113]Sevilla LM Bayo P Latorre V Mol Endocrinol 2010 24 2166 2178 20880987 PMC5417376
  111. [114]Bayo P Sanchis A Bravo A Endocrinology 2008 149 1377 1388 18039792
  112. [115]Yu XJ Ren XH Xu YH Neuropeptides 2010 44 407 411 20627382
  113. [116]Stojadinovic O Sawaya A Pastar I PLoS ONE 2013 8 e63453 23646206 PMC3639973
  114. [117]Tiala I Suomela S Huuhtanen J J Mol Med (Berl) 2007 85 589 601 17221218
  115. [118]Suomela S Elomaa O Skoog T PLoS ONE 2009 4 e6030 19551138 PMC2696036
  116. [119]Terao M Itoi S Murota H Exp Dermatol 2013 22 98 101 23362866
  117. [120]Jackson S Gilchrist H Nesbitt LT Jr Dermatol Ther 2007 20 187 205 17970885
  118. [121]Stahn C Lowenberg M Hommes DW Mol Cell Endocrinol 2007 275 71 78 17630118
  119. [122]Terao M Murota H Kimura A PLoS ONE 2011 6 e25039 21949844 PMC3176795
  120. [123]Slominski AT Kim TK Li W J Steroid Biochem Mol Biol 2013 doi: 10.1016/j.jsbmb. 2013.10.012. [Epub a head of print] · DOI
  121. [124]Slominski AT Carlson AJ Mayo Clin Proc 2014 89 429 433 24684870 PMC4050658
  122. [125]Slominski AT Kim T-K Shehabi HZ FASEB J 2012 26 3901 3915 22683847 PMC3425822
  123. [126]Slominski AT Kim TK Shehabi HZ Mol Cell Endocrinol 2014 383 181 192 24382416 PMC3997123

Cited by

Sorted by citations

Authors
Slominski, A. T., Manna, P. R., & Tuckey, R. C.
Affiliations
  • University of Tennessee Health Science Center (US)
  • Texas Tech University (US)
  • The University of Western Australia (AU)
Corresponding author
Slominski, Andrzej T.
Venue
Experimental Dermatology
Publisher
Wiley
Published
2014-05-28
Volume
23
Issue
6
Pages
369-374
ISSN
  • 0906-6705 (ISSN-L)
  • 1600-0625
OpenAlex
W2052241333
Cited by
79
References
131
Citations by year
2026: 3 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 6 · 2019: 10 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 11 · 2014: 6
FWCI
12.43
Type
journal article
Language
en
Open access
Locations
  • Experimental Dermatology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
Funders
  • National Science Foundation (0918934)
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (2R01AR052190-A6, R01AR052190, R01AR056666)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
glucocorticoid receptor, 7-dehydrocholesterol, UV-B radiation, vitamin D3, oxysterols, secosteroids, skin homeostasis, skin immune function, epidermis, cAMP/PKA signaling
MeSH terms
Adrenal Cortex Hormones, Glucocorticoids, Homeostasis, Humans, Skin, Skin Physiological Phenomena, Ultraviolet Rays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review